UBS Group AG
- SEC CIK
- 0001610520
- Latest filing
- Aug 13, 2026
NMTC holding history
Neuroone Medical Technologies Corp in every 13F filed by UBS Group AG, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
NMTC overviewAll 13F holders of NMTCFull Q2 2026 holdings
- Shares (Q2 2026)
- 2,623
- Value
- $7.97K
- % of portfolio
- <0.1%
- Quarters held
- 16
- Since Q2 2022
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 2,623 | $7.97K | <0.1% | +2,605+14,472.2% | AddedConverted for a 1-for-6 split | Holders |
| Q1 2026 | 108 | $84 | <0.1% | −1,817−94.4% | Reduced | Holders |
| Q4 2025 | 1,925 | $1.46K | <0.1% | +163+9.3% | Added | Holders |
| Q3 2025 | 1,762 | $1.57K | <0.1% | +1,654+1,531.5% | Added | Holders |
| Q2 2025 | 108 | $73 | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2025 | 108 | $92 | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2024 | 108 | $89 | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2024 | 108 | $107 | <0.1% | −57,195−99.8% | Reduced | Holders |
| Q2 2024 | 57,303 | $45.8K | <0.1% | +57,195+52,958.3% | Added | Holders |
| Q1 2024 | 108 | $130 | <0.1% | −1,777−94.3% | Reduced | Holders |
| Q4 2023 | 1,885 | $2.98K | <0.1% | +1,777+1,645.4% | Added | Holders |
| Q3 2023 | 108 | $96 | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2023 | 108 | $130 | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2023 | 108 | $174 | <0.1% | −1,090−91.0% | Reduced | Holders |
| Q4 2022 | 1,198 | $1.44K | <0.1% | +1,198 | New | Holders |
| Q3 2022 | 0 | $0 | 0.0% | −881−100.0% | Sold out | Holders |
| Q2 2022 | 881 | $1.00K | <0.1% | +881 | New | Holders |